在中央A3 - 氨酸受体的连接体亲和力中的物种差异
Xiao-Duo Ji1, Dag von Lubitz1, Mark E Olah2
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Drug development research
|January 17, 2024
概括
这项研究比较了不同物种在A3腺受体上的纯氨酸衍生物结合亲缘关系. 激进分子亲和力显示最小的物种依赖性,但对抗分子亲和力有所变化,突出了物种间的受体差异.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 氨酸受体,特别是A3亚型,是药物的关键标.
- 了解连接体的物种特异性结合亲缘关系对于药物开发和临床前研究至关重要.
- purin衍生物是一种与腺受体相互作用的重要化合物.
研究的目的:
- 为了比较不同物种在A3腺受体上的纯素衍生物的结合亲和力.
- 为了研究激素和对抗剂结合的物种依赖性变异.
- 评估[125I]AB-MECA作为A3受体研究中的高亲和度激素体配体的实用性.
主要方法:
- 使用[125I]AB-MECA,一种新型的高亲和力激动剂,进行了放射性体结合试验.
- 竞争约束测定与各种丁衍生物作为潜在的对抗剂进行.
- 实验使用了来自老鼠,大鼠和子的大脑膜,以及克隆的受体 (人类,绵羊,老鼠).
主要成果:
- 激动剂[125I]AB-MECA在老鼠大脑膜中表现出和性,特定的结合 (Kd=2.28 nM,Bmax=43 fmol/mg蛋白).
- [125I]AB-MECA的激素亲和力在老鼠,大鼠和子的A3受体中表现出类似的强度,这表明物种依赖程度低.
- 对手的亲和力在物种之间有所不同,在大鼠和子的A3受体中观察到一种特定的强度顺序.
- 与克隆羊和人类受体相比,大鼠,子和 gerbil 的 A3 受体对 8-Arylxanthine 的亲缘关系较低.
- 人类和老鼠的A3受体表现出类似的激素亲和力,而绵羊的A3受体表现出不同的激素结合特征.
结论:
- 在大鼠,大鼠和子物种中,A3腺素受体激动剂的亲和力在很大程度上保持不变.
- 在对抗剂在A3腺受体的结合配置上存在显著的物种差异.
- 这些发现强调了在药理学研究中考虑A3受体配体相互作用的物种变异性的重要性.
相关概念视频
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
880
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
880
Adrenergic Receptors (Adrenoceptors): Classification
2.6K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.6K
Dose-Response Relationship: Selectivity and Specificity
6.7K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.7K


